Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HP72
Term | Name | Level | Count |
---|---|---|---|
GO:0006486 | protein glycosylation | 4 | 1 |
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 4 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043413 | macromolecule glycosylation | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0070085 | glycosylation | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000030 | mannosyltransferase activity | 5 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016757 | glycosyltransferase activity | 3 | 12 |
GO:0016758 | hexosyltransferase activity | 4 | 12 |
GO:0000033 | alpha-1,3-mannosyltransferase activity | 6 | 2 |
GO:0052925 | dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity | 7 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.173 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.349 |
CLV_NRD_NRD_1 | 426 | 428 | PF00675 | 0.359 |
CLV_PCSK_FUR_1 | 423 | 427 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.249 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 194 | 196 | PF00082 | 0.173 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.360 |
CLV_PCSK_KEX2_1 | 425 | 427 | PF00082 | 0.361 |
CLV_PCSK_PC1ET2_1 | 118 | 120 | PF00082 | 0.260 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 425 | 427 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.499 |
DEG_MDM2_SWIB_1 | 129 | 136 | PF02201 | 0.336 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.617 |
DEG_SCF_FBW7_1 | 385 | 391 | PF00400 | 0.335 |
DOC_CKS1_1 | 385 | 390 | PF01111 | 0.335 |
DOC_MAPK_gen_1 | 118 | 128 | PF00069 | 0.483 |
DOC_MAPK_gen_1 | 194 | 202 | PF00069 | 0.373 |
DOC_MAPK_gen_1 | 74 | 81 | PF00069 | 0.354 |
DOC_MAPK_MEF2A_6 | 109 | 116 | PF00069 | 0.441 |
DOC_MAPK_NFAT4_5 | 109 | 117 | PF00069 | 0.433 |
DOC_PP1_RVXF_1 | 192 | 199 | PF00149 | 0.545 |
DOC_PP2B_LxvP_1 | 178 | 181 | PF13499 | 0.301 |
DOC_PP2B_LxvP_1 | 20 | 23 | PF13499 | 0.409 |
DOC_PP4_FxxP_1 | 249 | 252 | PF00568 | 0.289 |
DOC_USP7_MATH_1 | 388 | 392 | PF00917 | 0.257 |
DOC_WW_Pin1_4 | 384 | 389 | PF00397 | 0.335 |
DOC_WW_Pin1_4 | 409 | 414 | PF00397 | 0.510 |
LIG_14-3-3_CanoR_1 | 119 | 124 | PF00244 | 0.360 |
LIG_14-3-3_CanoR_1 | 236 | 240 | PF00244 | 0.263 |
LIG_14-3-3_CanoR_1 | 277 | 287 | PF00244 | 0.544 |
LIG_14-3-3_CanoR_1 | 296 | 304 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 370 | 377 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 389 | 393 | PF00244 | 0.129 |
LIG_14-3-3_CanoR_1 | 99 | 108 | PF00244 | 0.398 |
LIG_Actin_WH2_2 | 179 | 196 | PF00022 | 0.330 |
LIG_Actin_WH2_2 | 37 | 52 | PF00022 | 0.354 |
LIG_APCC_ABBA_1 | 126 | 131 | PF00400 | 0.301 |
LIG_APCC_ABBA_1 | 21 | 26 | PF00400 | 0.419 |
LIG_BRCT_BRCA1_1 | 162 | 166 | PF00533 | 0.195 |
LIG_BRCT_BRCA1_1 | 223 | 227 | PF00533 | 0.286 |
LIG_BRCT_BRCA1_1 | 377 | 381 | PF00533 | 0.173 |
LIG_deltaCOP1_diTrp_1 | 131 | 139 | PF00928 | 0.358 |
LIG_DLG_GKlike_1 | 119 | 126 | PF00625 | 0.473 |
LIG_eIF4E_1 | 86 | 92 | PF01652 | 0.448 |
LIG_EVH1_1 | 384 | 388 | PF00568 | 0.335 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.388 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.530 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.195 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.489 |
LIG_FHA_1 | 263 | 269 | PF00498 | 0.447 |
LIG_FHA_1 | 298 | 304 | PF00498 | 0.469 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.249 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.260 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.530 |
LIG_FHA_2 | 327 | 333 | PF00498 | 0.419 |
LIG_FHA_2 | 415 | 421 | PF00498 | 0.689 |
LIG_IRF3_LxIS_1 | 110 | 117 | PF10401 | 0.373 |
LIG_LIR_Apic_2 | 247 | 252 | PF02991 | 0.291 |
LIG_LIR_Apic_2 | 363 | 368 | PF02991 | 0.195 |
LIG_LIR_Gen_1 | 131 | 141 | PF02991 | 0.336 |
LIG_LIR_Gen_1 | 238 | 249 | PF02991 | 0.318 |
LIG_LIR_Gen_1 | 265 | 272 | PF02991 | 0.271 |
LIG_LIR_Gen_1 | 378 | 388 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 401 | 407 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 107 | 111 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 131 | 136 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 238 | 244 | PF02991 | 0.227 |
LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 265 | 269 | PF02991 | 0.380 |
LIG_LIR_Nem_3 | 343 | 349 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 350 | 356 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 378 | 384 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 401 | 406 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.235 |
LIG_PCNA_PIPBox_1 | 33 | 42 | PF02747 | 0.249 |
LIG_PDZ_Class_3 | 443 | 448 | PF00595 | 0.601 |
LIG_Pex14_1 | 133 | 137 | PF04695 | 0.421 |
LIG_Pex14_1 | 237 | 241 | PF04695 | 0.249 |
LIG_Pex14_2 | 129 | 133 | PF04695 | 0.336 |
LIG_Pex14_2 | 233 | 237 | PF04695 | 0.241 |
LIG_Pex14_2 | 348 | 352 | PF04695 | 0.301 |
LIG_Pex14_2 | 403 | 407 | PF04695 | 0.341 |
LIG_SH2_CRK | 354 | 358 | PF00017 | 0.392 |
LIG_SH2_CRK | 46 | 50 | PF00017 | 0.260 |
LIG_SH2_CRK | 86 | 90 | PF00017 | 0.330 |
LIG_SH2_NCK_1 | 24 | 28 | PF00017 | 0.273 |
LIG_SH2_NCK_1 | 354 | 358 | PF00017 | 0.351 |
LIG_SH2_NCK_1 | 86 | 90 | PF00017 | 0.419 |
LIG_SH2_PTP2 | 185 | 188 | PF00017 | 0.421 |
LIG_SH2_STAP1 | 323 | 327 | PF00017 | 0.554 |
LIG_SH2_STAP1 | 349 | 353 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.195 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 222 | 225 | PF00017 | 0.260 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.269 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 349 | 352 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 354 | 357 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 362 | 365 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.255 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.386 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.470 |
LIG_SH3_3 | 284 | 290 | PF00018 | 0.554 |
LIG_SH3_3 | 382 | 388 | PF00018 | 0.323 |
LIG_SUMO_SIM_anti_2 | 11 | 18 | PF11976 | 0.399 |
LIG_SUMO_SIM_par_1 | 166 | 171 | PF11976 | 0.195 |
LIG_TRAF2_1 | 316 | 319 | PF00917 | 0.476 |
LIG_TYR_ITIM | 22 | 27 | PF00017 | 0.358 |
LIG_TYR_ITIM | 239 | 244 | PF00017 | 0.309 |
LIG_TYR_ITIM | 44 | 49 | PF00017 | 0.260 |
LIG_TYR_ITIM | 84 | 89 | PF00017 | 0.195 |
LIG_UBA3_1 | 111 | 118 | PF00899 | 0.462 |
LIG_WRC_WIRS_1 | 327 | 332 | PF05994 | 0.554 |
MOD_CDK_SPK_2 | 384 | 389 | PF00069 | 0.354 |
MOD_CDK_SPK_2 | 414 | 419 | PF00069 | 0.592 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.554 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.530 |
MOD_CK2_1 | 326 | 332 | PF00069 | 0.468 |
MOD_CK2_1 | 414 | 420 | PF00069 | 0.676 |
MOD_Cter_Amidation | 152 | 155 | PF01082 | 0.412 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.335 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.548 |
MOD_GlcNHglycan | 395 | 398 | PF01048 | 0.223 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.306 |
MOD_GSK3_1 | 322 | 329 | PF00069 | 0.441 |
MOD_GSK3_1 | 380 | 387 | PF00069 | 0.258 |
MOD_N-GLC_1 | 298 | 303 | PF02516 | 0.173 |
MOD_N-GLC_2 | 130 | 132 | PF02516 | 0.317 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.452 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.306 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.473 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.301 |
MOD_NEK2_1 | 340 | 345 | PF00069 | 0.499 |
MOD_NEK2_1 | 352 | 357 | PF00069 | 0.281 |
MOD_NEK2_1 | 360 | 365 | PF00069 | 0.308 |
MOD_NEK2_1 | 393 | 398 | PF00069 | 0.360 |
MOD_PIKK_1 | 375 | 381 | PF00454 | 0.173 |
MOD_PKA_2 | 147 | 153 | PF00069 | 0.329 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.260 |
MOD_PKA_2 | 388 | 394 | PF00069 | 0.173 |
MOD_Plk_1 | 298 | 304 | PF00069 | 0.418 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.383 |
MOD_Plk_4 | 262 | 268 | PF00069 | 0.335 |
MOD_Plk_4 | 299 | 305 | PF00069 | 0.546 |
MOD_Plk_4 | 323 | 329 | PF00069 | 0.459 |
MOD_Plk_4 | 347 | 353 | PF00069 | 0.386 |
MOD_Plk_4 | 388 | 394 | PF00069 | 0.301 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.325 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.360 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.259 |
MOD_ProDKin_1 | 384 | 390 | PF00069 | 0.335 |
MOD_ProDKin_1 | 409 | 415 | PF00069 | 0.518 |
TRG_DiLeu_BaEn_1 | 80 | 85 | PF01217 | 0.173 |
TRG_DiLeu_BaEn_3 | 34 | 40 | PF01217 | 0.335 |
TRG_ENDOCYTIC_2 | 185 | 188 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.346 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.266 |
TRG_ENDOCYTIC_2 | 241 | 244 | PF00928 | 0.309 |
TRG_ENDOCYTIC_2 | 349 | 352 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.251 |
TRG_ENDOCYTIC_2 | 86 | 89 | PF00928 | 0.330 |
TRG_ER_diArg_1 | 193 | 195 | PF00400 | 0.373 |
TRG_ER_diArg_1 | 270 | 273 | PF00400 | 0.318 |
TRG_NLS_MonoExtC_3 | 424 | 430 | PF00514 | 0.522 |
TRG_NLS_MonoExtN_4 | 423 | 429 | PF00514 | 0.642 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7A1 | Leptomonas seymouri | 57% | 92% |
A0A0S4J269 | Bodo saltans | 39% | 100% |
A0A1X0P7P8 | Trypanosomatidae | 45% | 100% |
A0A3R7K2K2 | Trypanosoma rangeli | 43% | 100% |
A0A3S7XAS6 | Leishmania donovani | 76% | 100% |
A1CBE6 | Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) | 33% | 95% |
A1DDZ3 | Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) | 32% | 100% |
A2RA94 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 30% | 100% |
A3LTB7 | Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) | 27% | 94% |
A4IDH7 | Leishmania infantum | 76% | 100% |
A5DJQ5 | Meyerozyma guilliermondii (strain ATCC 6260 / CBS 566 / DSM 6381 / JCM 1539 / NBRC 10279 / NRRL Y-324) | 29% | 94% |
D0A365 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9ASY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
O82244 | Arabidopsis thaliana | 35% | 100% |
P0CN92 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 31% | 100% |
P0CN93 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 31% | 100% |
P38179 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 33% | 98% |
P82149 | Drosophila melanogaster | 36% | 93% |
Q24332 | Drosophila virilis | 33% | 85% |
Q2U6A4 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 31% | 100% |
Q4Q1L8 | Leishmania major | 77% | 100% |
Q4WVG2 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 31% | 100% |
Q55F69 | Dictyostelium discoideum | 31% | 100% |
Q6BYY8 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 29% | 93% |
Q6CMF1 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 32% | 97% |
Q6DNA2 | Komagataella phaffii (strain GS115 / ATCC 20864) | 29% | 96% |
Q6FXS2 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 31% | 100% |
Q751K5 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 34% | 100% |
Q8K2A8 | Mus musculus | 38% | 100% |
Q92685 | Homo sapiens | 37% | 100% |
Q9C1K8 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 34% | 100% |
Q9Y7I4 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 100% |
V5BKW5 | Trypanosoma cruzi | 44% | 100% |